Inje University Ilsan Paik Hospital
| 大韓民国 | トルコ | オーストリア | |
| 鼻形成術 | から $5,824 | から $3,487 | から $7,000 |
| 陰茎増大術 | から $4,200 | から $3,500 | から $6,500 |
| 豊胸術 | から $6,800 | から $3,767 | から $6,000 |
| 自毛植毛術 | から $3,900 | から $2,300 | から $5,000 |
| 腹部形成術 | から $2,000 | から $5,498 | から $8,500 |
ユ・ホ・ド博士は、韓国のソウル・トゥデイ歯科クリニックの歯科医師です。米国ジョンズ・ホプキンス大学で二重学位を取得しています。神経科学、応用数学、統計学の背景を持っています。ソウル大学校で歯科の学位を取得しました。ド博士は、歯科インプラントと修復処置を専門としています。
Professor Hwang Sung-joo is Director of the Hair Transplant Center at Myongji Hospital. He is an internationally recognized hair restoration surgeon with more than 30 years of experience. He performs FUT, FUE, and complex repair procedures. He has transplanted about 50 million hairs.
He was the first Korean President of the ISHRS. He founded and led the Asian and Korean hair restoration surgery societies. He received the ISHRS Platinum Follicle Award. He developed DCT (Depth Controlled Transplantation) and an implantation device to improve graft survival. He performed Korea’s first sister-to-sister hair transplant after bone marrow transplantation in 2005, and a mother-to-daughter transplant in 2025. He wrote a Korean textbook and co-wrote U.S. and Asian texts.
Professor Lee Seok-gu is a leading liver transplant surgeon at Myongji Hospital. He has performed about 2,000 liver transplants. He achieved Korea’s first transfusion-free liver transplant. He performed hepatocyte transplantation in a one-month-old infant. He led the first clinical use of a bioartificial liver for acute liver failure. He also performed living-donor transplants in Egypt and trained teams in Vietnam.
He is Professor of Surgery at Myongji Hospital and former Director of the Organ Transplantation Center at Samsung Medical Center. He earned his MD and MSc from Seoul National University and his PhD from the Catholic University of Korea. He completed a fellowship at Boston Children’s Hospital/Harvard and transplant training at Johns Hopkins. He served as president of three national societies in transplantation and pediatric surgery. His honors include the Chong Kun Dang Award, the Pfizer Clinical Medicine Award, and the Astellas Investigator Award. He has 447 publications and 13 book chapters.
Professor Kim Ki-bong specializes in CABG, valve surgery, atrial fibrillation, and heart transplantation. He is Director of the Cardiac Surgery and Cardiovascular Centers at Myongji Hospital. He pioneered advanced coronary bypass in Korea. He has extensive OPCAB experience and works on the TECAB team using the da Vinci Xi.
In 2025, his team performed Korea’s first totally endoscopic CABG without cardiopulmonary bypass. In August 2026, they achieved the nation’s first multivessel TECAB.
He is former Chair of Thoracic and Cardiovascular Surgery at Seoul National University College of Medicine. He is also former Chief of the same department at Seoul National University Hospital. He serves on the Editorial Board of The Annals of Thoracic Surgery. He is a member of AATS, STS, and EACTS. He is a past President of the Korean Societies of Coronary Artery Surgery, Surgical Treatment of Arrhythmias, and Thoracic and Cardiovascular Surgery. His research includes 130+ international and 140+ Korean papers. He has given 80+ international and 80+ Korean lectures. He earned his MD, Master’s, and PhD at Seoul National University.